<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1807222306
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2004
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LOVRAK 800 mg tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ACYCLOVIR
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        800
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        121.10
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J05AB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Lovrak </strong>contains a medicine called acyclovir. This belongs to a group of medicines called antivirals. It works by killing or stopping the growth of viruses.</p><p><strong>Lovrak </strong><strong>can be used to: </strong></p><p>&bull; treat chickenpox and shingles</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Lovrak: </strong></p><p>&bull; if you are allergic to acyclovir or valacyclovir or any of the other ingredients of this medicine (listed in Section 6).</p><p>Do not take <strong>Lovrak</strong> if the above applies to you. If you are not sure, talk to your doctor &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or pharmacist before taking <strong>Lovrak</strong>.</p><p><strong>Warnings and precautions </strong></p><p>Talk to your doctor or pharmacist before taking <strong>Lovrak </strong>if:</p><p>&bull; you have kidney problems</p><p>&bull; you are over 65 years of age.</p><p>If you are not sure if the above apply to you, talk to your doctor or pharmacist before taking <strong>Lovrak</strong>.</p><p>It is important that you drink plenty of water while taking <strong>Lovrak</strong>.</p><p><strong>Other medicines and Lovrak </strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription, including herbal medicines.</p><p>In particular, tell your doctor or pharmacist if you are taking any of the following medicines:</p><p>&bull; probenecid, used to treat gout</p><p>&bull; cimetidine, used to treat stomach ulcers</p><p>&bull; mycophenolate mofetil, used to stop your body rejecting transplanted organs.</p><p><strong>Pregnancy, breast-feeding and fertility </strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><strong>Driving and using machines </strong></p><p>Some side effects such as feeling drowsy or sleepy may impair your ability to concentrate and react. Make sure you are not affected before you drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p><strong>Taking this medicine </strong></p><p>&bull; Take this medicine by mouth</p><p>&bull; Swallow the whole tablet with a little water.</p><p>&bull; Start to take <strong>Lovrak </strong>as soon as possible.</p><p>The dose that you should take will depend on what you have been given <strong>Lovrak </strong>for. Your doctor will discuss this with you.</p><p><strong>Treatment of chickenpox and shingles </strong></p><p>&bull; The usual dose is one 800mg tablet five times a day</p><p>&bull; You should space each dose by 4 hours</p><p>Suggested times are: <strong>7am, 11am, 3pm, 7pm and 11pm </strong></p><p>&bull; You should take <strong>Lovrak </strong>for seven days.</p><p><strong>Your doctor may adjust the dose of Lovrak if: </strong></p><p>&bull; it is for a child</p><p>&bull; you are over 65 years of age</p><p>&bull; you have kidney problems. If you have kidney problems, it is important to drink plenty of water while you are being treated with <strong>Lovrak</strong>.</p><p>Talk to your doctor before taking <strong>Lovrak </strong>if any of the above apply.</p><p><strong>If you take more Lovrak than you should </strong></p><p><strong>Lovrak </strong>is not usually harmful, unless you take too much over several days. Talk to your doctor or pharmacist if you take too much <strong>Lovrak</strong>. Take the medicine pack with you.</p><p><strong>If you forget to take Lovrak </strong></p><p>&bull; If you forget to take <strong>Lovrak</strong>, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose.</p><p>&bull; Do not take a double dose to make up for a forgotten dose.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:</p><p><strong>Allergic</strong> <strong>reactions</strong> (may affect up to 1 in 1,000 people)</p><p>If you have an allergic reaction, <strong>stop taking Lovrak and see a doctor straight away</strong>. The signs may include:</p><p>&bull; rash, itching or hives on your skin</p><p>&bull; swelling of your face, lips, tongue or other parts of your body</p><p>&bull; shortness of breath, wheezing or trouble breathing</p><p>collapse</p><p><strong><u>Other side effects include: </u></strong></p><p><strong>Common </strong>(may affect up to 1 in 10 people)</p><p>&bull; headache</p><p>&bull; feeling dizzy</p><p>&bull; feeling or being sick</p><p>&bull; diarrhoea</p><p>&bull; stomach pains</p><p>&bull; rash</p><p>&bull; skin reaction after exposure to light (photosensitivity)</p><p>&bull; itching</p><p>&bull; feeling tired</p><p>&bull; unexplained fever (high temperature) and feeling faint, especially when standing up.</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>&bull; itchy, hive-like rash</p><p>&bull; hair loss.</p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><p>&bull; effects on some blood and urine tests</p><p>&bull; increases in the enzymes that work in the liver.</p><p><strong>Very rare </strong>(may affect up to 1 in 10,000 people)</p><p>&bull; reduced numbers of red blood cells (anaemia)</p><p>&bull; reduced numbers of white blood cells (leukopenia)</p><p>&bull; reduced numbers of blood platelets (cells that help blood to clot) (thrombocytopenia)</p><p>&bull; feeling weak</p><p>&bull; feeling agitated or confused</p><p>&bull; shaking or tremors</p><p>&bull; hallucinations (seeing or hearing things that aren&rsquo;t there)</p><p>&bull; fits</p><p>&bull; feeling unusually sleepy or drowsy</p><p>&bull; unsteadiness when walking and lack of coordination</p><p>&bull; difficulty speaking</p><p>&bull; inability to think or judge clearly</p><p>&bull; unconsciousness (coma)</p><p>&bull; paralysis of part or all of your body</p><p>&bull; disturbances of behaviour, speech and eye movements</p><p>&bull; stiff neck and sensitivity to light</p><p>&bull; inflammation of the liver (hepatitis)</p><p>&bull; yellowing of your skin and whites of your eyes (jaundice)</p><p>&bull; kidney problems where you pass little or no urine</p><p>&bull; pain in your lower back, the kidney area of your back or just above your hip (renal pain).</p><p><strong>&nbsp;</strong></p><p><strong><u>Reporting of side effects </u></strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:</p><p>&sect; <strong>Saudi</strong><strong> Arabia:</strong></p><p><strong>&nbsp; The National Pharmacovigilance Centre (NPC):</strong></p><p>-&nbsp; <strong>Fax: </strong>+966-11-205-7662</p><p>-&nbsp; <strong>SFDA Call Centre:</strong> 19999</p><p>-&nbsp; <strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p>-&nbsp; <strong>Website: </strong>https://ade.sfda.gov.sa</p><p>&sect; <strong>Other</strong><strong> GCC States:</strong></p><p>-&nbsp; Please contact the relevant competent authority.</p><p>By reporting side effects, you can help provide more information on the safety of this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp; Do not take <strong>Lovrak </strong>after the expiry date which is stated on the carton and on the blister.</p><p>-&nbsp; Store below 30&deg;C.</p><p>-&nbsp; Do not take<strong> Lovrak </strong>if you notice any visible sign of deterioration.</p><p>-&nbsp; Medicines should<em> </em>not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is acyclovir. Each film-coated tablet contains 800mg of acyclovir.</p><p>The other ingredients: Microcrystalline cellulose, sodium starch glycolate, maize starch, magnesium stearate, hypromellose, polyethylene glycol, talc and titanium dioxide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Lovrak film-coated tablets are available in packs of 20 tablets (2 blisters of 10 tablets each).                                                                                                                                                            
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                21/12/2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي<strong> </strong><strong>لفراك </strong>على المادة الفعالة أسيكلوفير، التي تنتمي إلى مجموعة من الأدوية تعرف باسم الأدوية المضادة للفيروسات. يعمل <strong>لفراك </strong>عن طريق القضاء على الفيروسات أو إيقاف نموها.</p><p dir="RTL"><strong>من الممكن استعمال </strong><strong>لفراك</strong><strong> </strong><strong>في الحالات التالية:</strong></p><p>علاج الجديري المائي والهربس النطاقي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عليك عدم تناول لفراك &nbsp;في الحالات التالية:</strong></p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من الحساسية تجاه أسيكلوفير أو فالاسيكلوفير أو أياً من المكونات الأخرى في هذا الدواء&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (المذكورة في &nbsp;بند رقم 6).</p><p dir="RTL">يجب عدم تناول <strong>لفراك </strong>إذا كان أياً مما ذكر أعلاه ينطبق عليك. يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>لفراك</strong>، ما لم تكن متأكداً من ذلك.</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>لفراك </strong>في الحالات التالية:</p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من مشاكل في الكلى</p><p dir="RTL">&bull;&nbsp; إذا كنت بعمر أكبر من 65 عاماً</p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>لفراك</strong>، في حال لم تكن متأكداً ما إذا كان أياً مما ذكر أعلاه ينطبق عليك.</p><p dir="RTL">يجب عليك الحرص على شرب كميات وفيرة من الماء أثناء فترة تناول <strong>لفراك</strong></p><p dir="RTL"><strong>تناول الأدوية الأخرى بالتزامن مع لفراك</strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول، تناولت مؤخراً أو قد تتناول أية أدوية أخرى، على سبيل المثال الأدوية التي تصرف دون وصفة طبية بما في ذلك الأدوية العشبية.</p><p dir="RTL">وبصفة خاصة، يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول أياً من الأدوية التالية:</p><p dir="RTL">&bull;&nbsp; بروبينسيد، يستخدم لعلاج داء النقرس</p><p dir="RTL">&bull;&nbsp; سيميتيدين، يستخدم لعلاج قرحات المعدة</p><p dir="RTL">&bull;&nbsp; ميكوفينوليت موفيتيل، يستخدم لمنع رفض الجسم للأعضاء المزروعة.</p><p dir="RTL"><strong>الحمل، الرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعاملين معه للحصول على النصيحة قبل تناول هذا الدواء، إذا كنت حاملاً أو ترضعين طفلك رضاعة طبيعية، تعتقدين أنك حاملاً أو تخططين لإنجاب طفلاً.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد تؤثر بعض التأثيرات الجانبية على سبيل المثال الشعور بالنعاس على قدرتك على التركيز وعلى نشاطك اليومي. احرص على أن تكون بحالة جيدة قبل القيادة أو تشغيل الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك دائماً تناول هذا الدواء<strong> </strong>بدقة<strong> </strong>وفقاً لتعليمات طبيبك المعالج. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه في حال لم تكن متأكداً من ذلك.</p><p dir="RTL"><strong>حول تناول هذا الدواء</strong></p><p dir="RTL">&bull;&nbsp; قم بتناول هذا الدواء عن طريق الفم</p><p dir="RTL">&bull;&nbsp; قم بابتلاع القرص كاملاً مع شرب كمية قليلة من الماء.</p><p dir="RTL">&bull;&nbsp; قم ببدأ تناول <strong>لفراك</strong> في أقرب وقت ممكن</p><p dir="RTL">سوف يعتمد مقدار الجرعة الواجب عليك تناولها على الحالة المرضية التي تعاني منها. سوف يتناقش معك طبيبك المعالج حول ذلك.</p><p dir="RTL"><strong>علاج الجديري المائي والهربس النطاقي</strong></p><p dir="RTL">&bull;&nbsp; يبلغ مقدار الجرعة الاعتيادية قرص واحد 800 ملغم ويتم تناولها خمسة مرات يومياً.</p><p dir="RTL">&bull;&nbsp; يجب عليك ترك 4 ساعات فاصلة بين كل جرعة وأخرى.</p><p dir="RTL">الأوقات المقترحة هي<strong>: 7 صباحاً، 11 صباحاً، 3 مساءً، 7 مساءً و 11 مساءً</strong></p><p dir="RTL"><strong>&bull;&nbsp; </strong>يجب عليك تناول <strong>لفراك </strong>لمدة 7 أيام</p><p dir="RTL"><strong>قد يقوم طبيبك المعالج بتعديل مقدار الجرعة من </strong><strong>لفراك في الحالات التالية:</strong></p><p dir="RTL">&bull;&nbsp; إذا كان المريض طفلاً</p><p dir="RTL">&bull;&nbsp; إذا كنت بعمر أكبر من 65 عاماً&nbsp;</p><p dir="RTL">&bull;&nbsp; إذا كنت تعاني من مشاكل في الكلى. من المهم تناول كميات وفيرة من الماء أثناء فترة العلاج باستعمال <strong>لفراك، </strong>في حال كنت تعاني من مشاكل في الكلى.</p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج قبل تناول <strong>لفراك</strong> إذا كان أياً مما ذكر أعلاه ينطبق عليك.</p><p dir="RTL"><strong>إذا تناولت </strong><strong>لفراك بجرعة أكبر مما يجب</strong></p><p dir="RTL">عادةً لا يتسبب <strong>لفراك </strong>في حدوث أية أضرار، إلا في حال تناول جرعات مفرطة على مدى عدة أيام. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا تناولت <strong>لفراك </strong>بجرعة أكبر مما يجب. يجب عليك أخذ عبوة الدواء معك.</p><p dir="RTL"><strong>إذا سهوت عن تناول لفراك </strong></p><p dir="RTL">&bull;&nbsp; إذا سهوت عن تناول <strong>لفراك</strong>، فيجب عليك تناولها في أسرع وقت ممكن في حال تذكرها. على الرغم من ذلك، في حال اقتراب موعد تناول الجرعة التالية، فيجب عليك التخطي عن تناول الجرعة التي قد سهوت عن تناولها.</p><p dir="RTL">&bull;&nbsp; يجب عليك عدم تناول جرعة مضاعفة لتعويض الجرعة التي قد سهوت عنها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو عليه الحال مع جميع الأدوية، من الممكن أن يؤدي هذا الدواء<strong> </strong>إلى حدوث تأثيرات جانبية، على الرغم من ذلك</p><p dir="RTL">فإنها قد لا تحدث ذلك لكل شخص. قد تحدث التأثيرات الجانبية التالية أثناء فترة تناول هذا الدواء:</p><p dir="RTL"><strong>التفاعلات التحسسية </strong>(قد تؤثر على ما يصل إلى شخص واحد من كل 1000 شخص)</p><p dir="RTL"><strong>يرجى منك التوقف عن تناول لفراك ورؤية طبيبك المعالج على الفور،</strong> إذا كنت تعاني من التفاعلات التحسسية.</p><p dir="RTL">قد تتضمن العلامات التي تدل على حدوث ذلك على:</p><p dir="RTL">&bull;&nbsp; طفح جلدي، حكة أو طفح جلدي على شكل خلايا النحل</p><p dir="RTL">&bull;&nbsp; تورم الوجه، الشفتين، اللسان أو الأجزاء الأخرى من الجسم</p><p dir="RTL">&bull;&nbsp; ضيق في التنفس، أزيز أو صعوبة في التنفس</p><p dir="RTL">&bull;&nbsp; تدهور عام في الصحة</p><p dir="RTL"><strong><u>تتضمن التأثيرات الجانبية الأخرى على:</u></strong></p><p dir="RTL"><strong>شائعة </strong>(قد تؤثر على ما يصل إلى شخص واحد من كل 10 أشخاص)</p><p dir="RTL">&bull;&nbsp; صداع</p><p dir="RTL">&bull;&nbsp; الشعور بالدوخة</p><p dir="RTL">&bull;&nbsp; الشعور بالإعياء أو التوعك</p><p dir="RTL">&bull;&nbsp; الإسهال</p><p dir="RTL">&bull;&nbsp; آلام في المعدة</p><p dir="RTL">&bull;&nbsp; طفح جلدي</p><p dir="RTL">&bull;&nbsp; حدوث تفاعلات جلدية بعد التعرض للضوء (الحساسية تجاه الضوء)</p><p dir="RTL">&bull;&nbsp; حكة</p><p dir="RTL">&bull;&nbsp; الشعور بالتعب</p><p dir="RTL">&bull;&nbsp; حدوث حمى غير مبررة السبب (ارتفاع درجة الحرارة) والشعور بالإغماء، وبصفة خاصة عند الوقوف</p><p dir="RTL"><strong>غير شائعة </strong>(قد تؤثر على ما يصل إلى شخص واحد من كل 100 شخص)</p><p dir="RTL">&bull;&nbsp; حكة، طفح جلدي على شكل خلايا النحل</p><p dir="RTL">&bull;&nbsp; سقوط الشعر</p><p dir="RTL"><strong>نادرة </strong>(قد تؤثر على ما يصل إلى شخص واحد من كل 1000 شخص)</p><p dir="RTL">&bull;&nbsp; تأثيرات على بعض فحوصات الدم أو البول</p><p dir="RTL">&bull;&nbsp; ارتفاع إنزيمات الكبد</p><p dir="RTL"><strong>نادرة جداً </strong>(قد تؤثر على ما يصل إلى شخص واحد من كل 10000 شخص)</p><p dir="RTL">&bull;&nbsp; انخفاض تعداد خلايا الدم الحمراء (فقر الدم)</p><p dir="RTL">&bull;&nbsp; انخفاض تعداد خلايا الدم البيضاء (قلة الكريات البيضاء)</p><p dir="RTL">&bull;&nbsp; انخفاض تعداد الصفائح الدموية (الخلايا التي تساعد الدم على التخثر) (قلة الصفيحات)</p><p dir="RTL">&bull;&nbsp; الشعور بالضعف</p><p dir="RTL">&bull;&nbsp; الشعور بالتهيج أو الارتباك</p><p dir="RTL">&bull;&nbsp; ارتعاش</p><p dir="RTL">&bull;&nbsp; هلوسة (رؤية أو سماع أشياء وهمية)</p><p dir="RTL">&bull;&nbsp; اختلاجات</p><p dir="RTL">&bull;&nbsp; الشعور بالنعاس بصورة غير معتادة</p><p dir="RTL">&bull;&nbsp; الترنح أثناء المشي وعدم تناسق الحركة</p><p dir="RTL">&bull;&nbsp; صعوبة في الكلام</p><p dir="RTL">&bull;&nbsp; عدم القدرة على التفكير أو اتخاذ القرار بصورة واضحة</p><p dir="RTL">&bull;&nbsp; فقدان الوعي (غيبوبة)</p><p dir="RTL">&bull;&nbsp; شلل جزء أو جميع أجزاء الجسم</p><p dir="RTL">&bull;&nbsp; اضطراب في السلوك الشخصي، الكلام وحركة العينين</p><p dir="RTL">&bull;&nbsp; تصلب الرقبة والحساسية تجاه الضوء</p><p dir="RTL">&bull;&nbsp; التهاب الكبد</p><p dir="RTL">&bull;&nbsp; اصفرار لون الجلد وبياض العينين (اليرقان)</p><p dir="RTL">&bull;&nbsp; مشاكل في الكلى التي تتمثل في &nbsp;قلة التبول أو عدم التبول</p><p dir="RTL">&bull;&nbsp; ألم أسفل الظهر، منطقة الكلية من الناحية الخلفية في منطقة الظهر أو مباشرة فوق منطقة الورك (الألم الكلوي)</p><p dir="RTL"><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong></p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه، في حال حدوث أياً من التأثيرات الجانبية، بما في ذلك أية تأثيرات جانبية يحتمل حدوثها ولم يتم ذكرها في هذه النشرة. كما يمكنك الإبلاغ عن التأثيرات الجانبية مباشرة عن طريق:</p><p dir="RTL"><strong>&sect;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية:</strong></p><p dir="RTL"><strong>المركز الوطني للتيقظ الدوائي:</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp; <strong>رقم الفاكس:</strong> 7662-205-11-966+</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; <strong>مركز الاتصال الموحد:</strong> 19999</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; <strong>البريد الإلكتروني:</strong>&nbsp; npc.drug@sfda.gov.sa</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; ا<strong>لموقع الإلكتروني:</strong> &nbsp;https://ade.sfda.gov.sa</p><p dir="RTL">&sect;&nbsp;&nbsp; <strong>دول الخليج العربي الأخرى:</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;الرجاء الاتصال بالجهات الوطنية في كل دولة.</p><p dir="RTL">إن تسجيل التأثيرات الجانبية يساعد في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p dir="RTL">-&nbsp;&nbsp; يجب عدم تناول <strong>لفراك &nbsp;</strong>بعد تاريخ انتهاء الصلاحية المذكور على العبوة والشريط.</p><p dir="RTL">-&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30&deg;م.</p><p dir="RTL">-&nbsp;&nbsp; يجب عدم تناول <strong>لفراك </strong>إذا لاحظت وجود علامات تلف واضحة.</p><p dir="RTL">-&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي أسيكلوفير. يحتوي كل قرص مكسو على 800 ملغم من أسيكلوفير.</p><p dir="RTL">المواد الأخرى: بلورات سليلوز متناهية الصغر، نشا جلايكولات الصوديوم، نشا الذرة، ستيرات المغنيسيوم، هيبروميللوز، بولي إثيلين جلايكول، تلك، وثاني أكسيد التيتانيوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تتوفر أقراص <strong>لفراك</strong><strong> </strong>المكسوة في عبوات تحتوي على 20 قرصاً (شريطان، يحتوي كلاً منهما على 10 أقراص).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            2022/12/21 م
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lovrak 800mg Film- coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains:
Item No.    Material Name	                                     Scale (mg/Tablet)
Core Materials:
	Active Ingredient:	
1.		  Acyclovir 	                                            800.00
		
	Inactive Ingredients:	
1.		Microcrystalline Cellulose 
                (Avicel PH - 102)	                                     196.00
2.		Sodium Starch Glycolate (Premojel)   43.00
3.		Maize Starch	                                     40.00
4.		Magnesium Stearate	                             6.00
5.		Purified Water*	                                     q.s
		
       Coating Materials:
1.	       Hydroxypropyl methylcellulose 
               (hypromellose)	                                    6.191
2.	       Polyethylene Glycol - 6000	                    1.905
3.	       Talc Fine Powder	                                    0.952
4.	       Titanium Dioxide    	                            0.952
5.	       Purified Water*	                                    q.s
6.	       Ethanol 95%*	                                            q.s
*Evaporates during manufacturing process and does not appear in the final product.
Note: Quantity of microcrystalline cellulose (Avicel PH - 102) may vary to adjust the potency of Acyclovir. 

For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated Tablets
Description: White to off-white, oblong, film-coated tablet.
Marking: Face one: Plain 
Face two: Break-line
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Lovrak </strong>tablets 800mg<strong> </strong>are indicated for the treatment of varicella (chickenpox) and herpes zoster (shingles) infections (excluding neonatal HSV and severe HSV infections in immunocompromised children).</p><p><strong>Lovrak </strong>is recommended in children over the age of 6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Dosage in adults</u></strong><strong>:</strong></p><p><strong>Treatment of varicella and herpes zoster infections:</strong>&nbsp;</p><p>800 mg <strong>Lovrak</strong> should be taken five times daily at approximately four-hourly intervals, omitting the night time dose. Treatment should continue for seven days.</p><p>In severely immunocompromised patients (e.g. after marrow transplant) or in patients with impaired absorption from the gut, consideration should be given to intravenous dosing.</p><p>Dosing should begin as early as possible after the start of an infection: Treatment of herpes zoster yields better results if initiated as soon as possible after the onset of the rash. Treatment of chickenpox in immunocompetent patients should begin within 24 hours after the onset of the rash.</p><p><strong><u>Dosage in children:</u></strong></p><p><strong>Treatment of varicella infections:</strong></p><p>6 years and over: 800mg <strong>Lovrak</strong> four times daily.</p><p>Treatment should continue for five days.</p><p>No specific data are available on the treatment of herpes zoster infections in immunocompetent children.</p><p>For treatment of neonatal herpes virus infections, intravenous acyclovir is recommended.</p><p><strong><u>Dosage in the elderly</u></strong><strong>:</strong></p><p>The possibility of renal impairment in the elderly must be considered and the dosage should be adjusted accordingly (see Dosage in renal impairment below).</p><p>Adequate hydration of elderly patients taking high oral doses of acyclovir should be maintained.</p><p><strong><u>Dosage in renal impairment</u></strong><strong>:</strong></p><p>Caution is advised when administering acyclovir to patients with impaired renal function. Adequate hydration should be maintained.</p><p>In the treatment of herpes zoster infections it is recommended to adjust the dosage to 800mg Acyclovir twice daily at approximately twelve-hourly intervals for patients with severe renal impairment (creatinine clearance less than 10 ml/minute) and to 800mg Acyclovir three times daily at intervals of approximately eight hours for patients with moderate renal impairment (creatinine clearance in the range of 10-25 ml/minute).</p><p><strong><u>Administration</u></strong></p><p><strong>Lovrak </strong>tablets are for oral administration, swallowed whole with a little water. Ensure that patients on high doses of acyclovir are adequately hydrated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to acyclovir or valacyclovir, or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Use in patients with renal impairment and in elderly patients:</strong></p><p>Acyclovir is eliminated by renal clearance; therefore the dose must be adjusted in patients with renal impairment (see 4.2 Posology and Method of Administration). Elderly patients are likely to have reduced renal function and therefore the need for dose adjustment must be considered in this group of patients. Both elderly patients and patients with renal impairment are at increased risk of developing neurological side effects and should be closely monitored for evidence of these effects. In the reported cases, these reactions were generally reversible on discontinuation of treatment (see 4.8 Undesirable Effects). Prolonged or repeated courses of acyclovir in severely immune-compromised individuals may result in the selection of virus strains with reduced sensitivity, which may not respond to continued acyclovir treatment (see section 5.1).</p><p><strong>Hydration status:</strong><em>&nbsp;</em>Care should be taken to maintain adequate hydration in patients receiving high doses of acyclovir.</p><p>The risk of renal impairment is increased by use with other nephrotoxic drugs.</p><p>The data currently available from clinical studies is not sufficient to conclude that treatment with acyclovir reduces the incidence of chickenpox-associated complications in immunocompetent patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acyclovir is eliminated primarily unchanged in the urine via active renal tubular secretion. Any drugs administered concurrently that compete with this mechanism may increase acyclovir plasma concentrations. Probenecid and cimetidine increase the AUC of acyclovir by this mechanism, and reduce acyclovir renal clearance. Similarly increases in plasma AUCs of acyclovir and of the inactive metabolite of mycophenolate mofetil, an immunosuppresant agent used in transplant patients have been shown when the drugs are coadministered. However no dosage adjustment is necessary because of the wide therapeutic index of acyclovir.</p><p>An experimental study on five male subjects indicates that concomitant therapy with acyclovir increases AUC of totally administered&nbsp;<strong>theophylline</strong>&nbsp;with approximately 50%. It is recommended to measure plasma concentrations during concomitant therapy with acyclovir.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Pregnancy:</u></strong></p><p>The use of acyclovir should be considered only when the potential benefits outweigh the possibility of unknown risks.</p><p>A post-marketing acyclovir pregnancy registry has documented pregnancy outcomes in women exposed to any formulation of Acyclovir. The registry findings have not shown an increase in the number of birth defects amongst Acyclovir exposed subjects compared with the general population, and any birth defects showed no uniqueness or consistent pattern to suggest a common cause. Systemic administration of acyclovir in internationally accepted standard tests did not produce embryotoxic or teratogenic effects in rabbits, rats or mice. In a non-standard test in rats, foetal abnormalities were observed but only following such high subcutaneous doses that maternal toxicity was produced. The clinical relevance of these findings is uncertain.</p><p>Caution should however be exercised by balancing the potential benefits of treatment against any possible hazard. Findings from reproduction toxicology studies are included in Section 5.3.</p><p><strong><u>Breast-feeding</u></strong><strong>:</strong></p><p>Following oral administration of 200 mg Acyclovir five times a day, Acyclovir has been detected in breast milk at concentrations ranging from 0.6 to 4.1 times the corresponding plasma levels. These levels would potentially expose nursing infants to Acyclovir dosages of up to 0.3 mg/kg/day. Caution is therefore advised if Acyclovir is to be administered to a nursing woman.</p><p><strong><u>Fertility:</u></strong></p><p>There is no information on the effect of acyclovir on human female fertility.</p><p>In a study of 20 male patients with normal sperm count, oral acyclovir administered at doses of up to 1g per day for up to six months has been shown to have no clinically significant effect on sperm count, motility or morphology.</p><p>See clinical studies in section 5.2</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There have been no studies to investigate the effect of acyclovir on driving performance or the ability to operate machinery. A detrimental effect on such activities cannot be predicted from the pharmacology of the active substance, but the adverse event profile should be borne in mind.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The frequency categories associated with the adverse events below are estimates. For most events, suitable data for estimating incidence were not available. In addition, adverse events may vary in their incidence depending on the indication.</p><p>The following convention has been used for the classification of undesirable effects in terms of frequency: Very common &ge;1/10, common &ge;1/100 and &lt;1/10, uncommon &ge;1/1000 and &lt;1/100, rare &ge;1/10,000 and &lt;1/1000, very rare &lt;1/10,000.</p><p><strong><u>Blood and lymphatic system disorders:</u></strong></p><p><em>Very rare:&nbsp;</em>Anaemia, leukopenia, thrombocytopenia.</p><p><strong><u>Immune system disorders:</u></strong></p><p><em>Rare:&nbsp;</em>Anaphylaxis.</p><p><strong><u>Psychiatric and nervous system disorders:</u></strong></p><p><em>Common:&nbsp;</em>Headache, dizziness.</p><p><em>Very rare:&nbsp;</em>Agitation, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, convulsions, somnolence, encephalopathy, coma.</p><p>The above events are generally reversible and usually reported in patients with renal impairment or with other predisposing factors (see 4.4 Special Warnings and Precautions for Use).</p><p><strong><u>Respiratory, thoracic and mediastinal disorders:</u></strong></p><p><em>Rare:&nbsp;</em>Dyspnoea.</p><p><strong><u>Gastrointestinal disorders:</u></strong></p><p><em>Common:&nbsp;</em>Nausea, vomiting, diarrhoea, abdominal pains.</p><p><strong><u>Hepato-biliary disorders:</u></strong></p><p><em>Rare:</em>&nbsp;Reversible rises in bilirubin and liver related enzymes.</p><p><em>Very rare:</em>&nbsp;Hepatitis, jaundice.</p><p><strong><u>Skin and subcutaneous tissue disorders:</u></strong></p><p><em>Common:&nbsp;</em>Pruritus, rashes (including photosensitivity).</p><p><em>Uncommon:&nbsp;</em>Urticaria. Accelerated diffuse hair loss. Accelerated diffuse hair loss has been associated with a wide variety of disease processes and medicines. The relationship of the event to acyclovir therapy is uncertain.</p><p><em>Rare:&nbsp;</em>Angioedema</p><p><strong><u>Renal and urinary disorders:</u></strong></p><p><em>Rare:&nbsp;</em>Increases in blood urea and creatinine.</p><p><em>Very rare:&nbsp;</em>Acute renal failure, renal pain.</p><p>Renal pain may be associated with renal failure and crystalluria.</p><p><strong><u>General disorders and administration site conditions:</u></strong></p><p><em>Common</em>: Fatigue, fever.</p><p><strong><u>To report any side effect(s):</u></strong></p><p>&sect; <strong>Saudi</strong><strong> Arabia:</strong></p><p><strong>&nbsp; The National Pharmacovigilance Centre (NPC):</strong></p><p>-&nbsp; <strong>Fax: </strong>+966-11-205-7662</p><p>-&nbsp; <strong>SFDA Call Centre:</strong> 19999</p><p>-&nbsp; <strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p>-&nbsp; <strong>Website: </strong>https://ade.sfda.gov.sa</p><p>&sect; <strong>Other</strong><strong> GCC States:</strong></p><p>-&nbsp; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acyclovir is only partly absorbed in the gastrointestinal tract.</p><p>Patients have ingested overdoses of up to 20g acyclovir on a single occasion, usually without toxic effects. Accidental, repeated overdoses of oral acyclovir over several days have been associated with gastrointestinal effects (such as nausea and vomiting) and neurological effects (headache and confusion).</p><p>Overdosage of intravenous acyclovir has resulted in elevations of serum creatinine, blood urea nitrogen and subsequent renal failure. Neurological effects including confusion, hallucinations, agitation, seizures and coma have been described in association with intravenous overdosage.</p><p><strong>Management:</strong><em> </em>patients should be observed closely for signs of toxicity. Haemodialysis significantly enhances the removal of acyclovir from the blood and may, therefore, be considered a management option in the event of symptomatic overdose<em>.</em></p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong> Direct acting antivirals, Nucleosides and nucleotides excl. reverse transcriptase inhibitors</p><p><strong>ATC code:</strong> J05AB01.</p><p>Acyclovir is a synthetic purine nucleoside analogue with&nbsp;<em>in vitro&nbsp;</em>and&nbsp;<em>in vivo&nbsp;</em>inhibitory activity against human herpes viruses, including herpes simplex virus (HSV) types I and II and varicella zoster virus (VZV). The inhibitory activity of Acyclovir for HSV I and HSV II and VZV is highly selective. The enzyme thymidine kinase (TK) of normal, uninfected cells does not use Acyclovir effectively as a substrate, hence toxicity to mammalian host cells is low; however, TK encoded by HSV and VZV converts Acyclovir to Acyclovir monophosphate, a nucleoside analogue which is further converted to the diphosphate and finally to the triphosphate by cellular enzymes. Acyclovir triphosphate interferes with the viral DNA polymerase and inhibits viral DNA replication with resultant chain termination following its incorporation into the viral DNA.</p><p>Prolonged or repeated courses of Acyclovir in severely immuno-compromised individuals may result in the selection of virus strains with reduced sensitivity, which may not respond to continued Acyclovir treatment. Most of the clinical isolates with reduced sensitivity have been relatively deficient in viral TK, however, strains with altered viral TK or viral DNA polymerase have also been reported.&nbsp;<em>In vitro&nbsp;</em>exposure of HSV isolates to Acyclovir can also lead to the emergence of less sensitive strains. The relationship between the&nbsp;<em>in vitro</em>-determined sensitivity of HSV isolates and clinical response to Acyclovir therapy is not clear.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Absorption</u></strong></p><p>acyclovir is only partially absorbed from the gut. The average oral bioavailability varies between 10 and 20%. Under fasting conditions, mean peak concentrations (Cmax) of 0.4 microgram/ml are achieved at approximately 1.6 hours after a 200 mg dose administered as oral suspension or capsule. Mean peak plasma concentrations (C<sub>ssmax</sub>) increase to 0.7 microgram/ml (3.1 micromoles) at steady state following doses of 200 mg administered every four hours. A less than proportional increase is observed for C<sub>ssmax </sub>concentration following doses of 400 mg and 800 mg administered fourhourly, with values reaching 1.2 and 1.8 microgram/ml (5.3 and 8 micromoles), respectively.</p><p><strong><u>Distribution</u></strong></p><p>The mean volume of distribution of 26 L indicates that acyclovir is distributed within total body water. Apparent values after oral administration (Vd/F) ranged from 2.3 to 17.8 L/kg. As plasma protein binding is relatively low (9 to 33%), drug interactions involving binding site displacement are not anticipated. Cerebrospinal fluid concentration are approximately 50% of corresponding plasma concentration at steady-state.</p><p><strong><u>Metabolism</u></strong></p><p>acyclovir is predominantly excreted unchanged by the kidney. The only significant urinary metabolite is 9- [(carboxymethoxy) methyl guanine, and accounts for 10-15% of the dose excreted in the urine.</p><p><strong><u>Elimination</u></strong></p><p>In adults mean systemic exposure (AUC0-&infin;) to acyclovir ranges between 1.9 and 2.2 microgram*h/mL after a 200 mg dose. At this dose, the mean terminal plasma half-life after oral administration has been shown to vary between 2.8 and 4.1 hours.</p><p>Renal clearance of acyclovir (CLr= 14.3 L/h) is substantially greater than creatinine clearance, indicating that tubular secretion, in addition to glomerular filtration, contributes to the renal elimination of the drug. The half-life and total clearance of acyclovir are dependent on renal function. Therefore, dosage adjustment is recommended for renally impaired patients.</p><p>There are no pharmacokinetic data for the oral formulation in neonates. The only available pharmacokinetic data are for the IV formulation in this age group.</p><p><strong><em>Special patient populations</em></strong></p><p><em>Elderly</em></p><p>In the elderly patients with normal renal function total clearance falls with increasing age due to decreases in creatinine clearance. However, the possibility of renal impairment in the elderly must be considered and the dosage should be adjusted accordingly.</p><p><em>Renal impairment</em></p><p>In patients with chronic renal failure the mean terminal half-life was found to be 19.5 hours. The mean acyclovir half-life during haemodialysis was 5.7 hours. Plasma acyclovir concentration dropped approximately 60% during dialysis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Mutagenicity:</strong> The results of a wide range of mutagenicity tests&nbsp;in vitro&nbsp;and&nbsp;in vivo&nbsp;indicate that acyclovir is unlikely to pose a genetic risk to man.</p><p><strong>Carcinogenicity:</strong> Acyclovir was not found to be carcinogenic in long term studies in the rat and the mouse.</p><p><strong>Teratogenicity:</strong> Systemic administration of acyclovir in internationally accepted standard tests did not produce embryotoxic or teratogenic effects in rats, rabbits or mice.</p><p>In a non-standard test in rats, foetal abnormalities were observed, but only following such high subcutaneous doses that maternal toxicity was produced. The clinical relevance of these findings is uncertain.</p><p><strong>Fertility:</strong> Largely reversible adverse effects on spermatogenesis in association with overall toxicity in rats and dogs have been reported only at doses of acyclovir greatly in excess of those employed therapeutically. Two generation studies in mice did not reveal any effect of acyclovir on fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Inactive Ingredients:</u></strong></p><p>1. Microcrystalline Cellulose (Avicel PH - 102)</p><p>2. Sodium Starch Glycolate (Premojel)</p><p>3. Maize Starch</p><p>4. Magnesium Stearate</p><p>5. Purified Water*</p><p><strong><u>Coating Materials:</u></strong></p><p>1. Hydroxypropyl methylcellulose (hypromellose)</p><p>2. Polyethylene Glycol - 6000</p><p>3. Talc Fine Powder</p><p>4. Titanium Dioxide</p><p>5. Purified Water*</p><p>6. Ethanol 95%*</p><p>*Evaporates during manufacturing process and does not appear in the final product.</p><p><strong>Note:</strong> Quantity of microcrystalline cellulose (Avicel PH - 102) may vary to adjust the potency of Acyclovir.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no special requirements for use on handling of this product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                48 months from the date of manufacturing
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30˚C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>2x10&#39;s tablets in aluminium-PVC blister strips, packed in a printed carton along with a leaflet.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street.
Ras Al Khaimah - United Arab Emirates.
P.O. Box 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                21. December. 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>